Joining VeloClub not only supports the work we do, there are some fantastic benefits:
by Shane Stokes
May 17, 2017
In today’s Daily News Digest: Dumoulin dominates Giro time trial and takes Maglia Rosa; Peter Sagan wins stage 3 at the Amgen Tour of California; Van Vleuten triumphs in Durango-Durango event in the Basque Country; Quintana: ‘We lost more time than expected’; Thomas bounces back from stage 9 crash to nab second; Jungels stages recovery after Blockhaus disappointment; Aldag says it’s not certain yet that Cavendish will ride Tour de France; Van Garderen suffers further time loss; ASO and AEG agree on strategic partnership to develop cycling in Germany; California concussion incident raises questions, but what could have been done differently?; Diabetic rider Javier Megias chasing breakaway success at the Amgen Tour of California; Audio: Unnnamed rider suggests Movistar may have deliberately caused stage 9 crash; Video: The Maglia Rosa! 24 hours with Tom Dumoulin at the Giro d’Italia; Video: A near miss for Nairo Quintana; Video: Bob Jungels post-race interview from Stage 10 of the Giro d’Italia 2017; Video: Cyclist hit by bullet during bike ride; Video: Inside the Aqua Blue Sport team bus; Video: Dumoulin’s wayward elbows
There are always the clear contenders in the Amgen Tour of California: the obvious riders on the forefront of people’s minds when considering potential stage winners and overall contenders.
But in a sport as unpredictable as cycling, one where tactics, external influences such as the weather and even luck play a major part, there are also always wildcards that must be considered.
Such dark horses are those who can spring a surprise and take major success if things play out well for them.
Javier Megias is one of those. While many WorldTour riders have the Amgen Tour of California as just one of their season goals, aiming for a good performance in the course of their build-up for the Tour de France, others have built their entire season around peaking for the event.
For rider such as Megias and Pro Continental teams such as his Team Novo Nordisk, the Californian event is one of the major targets. There is no holding back. No eye on other events. This is the 100 percent race and, in theory at least, those with such a specific focus should be much closer to their own personal top level.
Click through to read more at CyclingTips.